Takatoshi Takubo Selected Research

Thrombocytopenia (Thrombopenia)

4/2017

Phase 1 study of ixazomib alone or combined with lenalidomide-dexamethasone in Japanese patients with relapsed/refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takatoshi Takubo Research Topics

Disease

4	Neoplasms (Cancer) 01/2018 - 09/2012
2	Neutropenia 01/2018 - 04/2017
1	Stomatitis 01/2018
1	Diarrhea 04/2017
1	Hypertension (High Blood Pressure) 04/2017
1	Hypokalemia 04/2017
1	Hyponatremia 04/2017
1	Leukopenia 04/2017
1	Lymphopenia (Lymphocytopenia) 04/2017
1	Multiple Myeloma 04/2017
1	Nausea 04/2017
1	Thrombocytopenia 3 04/2017
1	Thrombocytopenia (Thrombopenia) 04/2017
1	Prostatic Neoplasms (Prostate Cancer) 02/2015
1	Hodgkin Disease (Hodgkin's Disease) 07/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2014

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 05/2014 - 09/2012
2	ganitumabIBA 05/2014 - 09/2012
1	Aurora Kinase AIBA 01/2018
1	MLN 8237IBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2017
1	Pharmaceutical PreparationsIBA 04/2017
1	ixazomibIBA 04/2017
1	Prednisolone (Predate)FDA LinkGeneric 02/2015
1	orteronelIBA 02/2015
1	Brentuximab VedotinIBA 07/2014
1	Gemcitabine FDA Link 05/2014
1	Insulin-Like PeptidesIBA 05/2014
1	trebananibIBA 01/2013
1	Angiopoietin-1IBA 01/2013
1	Somatomedin Receptors (Somatomedin Receptor)IBA 09/2012

Therapy/Procedure

1	Castration 02/2015
1	Therapeutics 05/2014